| |
| |
|
|
A BILL TO BE ENTITLED
|
|
|
AN ACT
|
|
|
relating to access to medication-assisted treatment for opioid use |
|
|
disorder under Medicaid. |
|
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
|
SECTION 1. (a) In this section, "qualifying practitioner" |
|
|
has the meaning assigned by 21 U.S.C. Section 823(g)(2)(G)(iii). |
|
|
(b) Not later than November 1, 2019, the Health and Human |
|
|
Services Commission shall amend the commission's Medicaid |
|
|
Substance Use Disorder Services Medical Policy and any other |
|
|
provider or claims payment policy or manual necessary to authorize |
|
|
Medicaid medical benefits reimbursement for the prescribing of |
|
|
buprenorphine for the treatment of an opioid use disorder by an |
|
|
advanced practice registered nurse recognized by the Texas Board of |
|
|
Nursing as a clinical nurse specialist, nurse anesthetist, or nurse |
|
|
midwife, provided that the advanced practice registered nurse: |
|
|
(1) is a qualifying practitioner; and |
|
|
(2) has obtained a waiver from registration |
|
|
requirements as provided by 21 U.S.C. Section 823(g). |
|
|
SECTION 2. This Act takes effect immediately if it receives |
|
|
a vote of two-thirds of all the members elected to each house, as |
|
|
provided by Section 39, Article III, Texas Constitution. If this |
|
|
Act does not receive the vote necessary for immediate effect, this |
|
|
Act takes effect September 1, 2019. |